Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia.

Repeat IV administration of hMUT mRNA at 0.5 mg/kg every 2 weeks resulted in a pronounced and highly significant improvement in survival in severe MMA mice (n = 6/group, p < .001 from log-rank test, Fig. 3 a).

also in 132,142 other papers